Article
Successful induction of clinically competent dendritic cells from granulocyte colony-stimulating factor-mobilized monocytes for cancer vaccine therapy.
Cancer immunology, immunotherapy : CII - 1 Mar 2007
Ueda Yuji, Itoh Tsuyoshi, Fuji Nobuaki, Harada Sachio, Fujiki Hiroshi, Shimizu Keiji, Shiozaki Atsushi, Iwamoto Arihiro, Shimizu Takeshi, Mazda Osam, Kimura Takafumi, Sonoda Yoshiaki, Taniwaki Masafumi, Yamagishi Hisakazu
Abstract excerpt
Recent studies have suggested that dendritic cell (DC)-based immunotherapy is one promising approach for the treatment of cancer. We previously studied the clinical toxicity, feasibility, and efficacy of cancer vaccine therapy with peptide-pulsed DCs. In that study, we used granulocyte colony-stimulating factor (G-CSF)-mobilized peripheral blood monocytes as a cell source of DCs. However, previous investigations...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
